Table 1.
Control | Crotamine | ||
---|---|---|---|
Kidney (g) | 0.34 ± 0.01 | 0.33 ± 0.01 | |
Liver (g) | 1.14 ± 0.07 | 1.11 ± 0.09 | |
Heart (g) | 0.14 ± 0.01 | 0.13 ± 0.01 | |
Femur (cm) | 1.58 ± 0.01 | 1.56 ± 0.02 | |
Body Weight (g) | 25.78 ± 0.71 | 24.88 ± 0.72 | |
Food Intake (g/24 h/5 mice) | 83.50 ± 2.08 | 76.32 ± 1.95* | |
Water Intake (mL/24 h/5 mice) | 21.62 ± 0.72 | 18.39 ± 0.93* | |
Creatinine (mg/dL) | Plasma | 2.84 ± 0.61 | 2.39 ± 0.42 |
Urine | 3.86 ± 0.07 | 2.91 ± 0.48 | |
Uric acid (mg/dL) | Plasma | 1.55 ± 1.01 | 1.89 ± 0.64 |
Urine | 2.30 ± 0.53 | 3.73 ± 0.40 |
Measurements of body and organs weights, femur size and plasma and urine biochemical biomarkers analyses were performed at the end of the treatment for 21 days with crotamine (1 μg/animal/day). For food and water intake assessment measures were performed at every 4 days, and the presented data correspond to the final mean value of consumption after the end of 21 days treatment period.
*p < 0.05 for t-Student statistical test. Results are expressed as mean ± SEM (N = 5 per group).